MAD1 Antibodies

Santa Cruz Biotechnology delivers a wide array of MAD1 Antibodies for investigating cellular processes. MAD1 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).MAD1, or Mitotic Arrest Deficient 1, is essential for the proper regulation of the cell cycle, particularly during the mitotic checkpoint. MAD1 plays a crucial role in ensuring that cells do not proceed to anaphase until all chromosomes are correctly attached to the spindle apparatus, thereby preventing chromosomal instability. Understanding MAD1 function is vital for research into various diseases, including cancer, where cell cycle regulation is often disrupted. MAD1 research has revealed significant insights into chromosome segregation and cell division mechanisms. Investigating MAD1 helps advance knowledge about mitotic checkpoint control and its relationship to genomic stability. Research focusing on MAD1 continues to uncover new aspects of cell cycle regulation and potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of cell cycle regulation and disease mechanisms.